首页> 外文会议>World biomaterials congress >The effect of drug loading technics on in vitro release profile from multifunctional chitosan/polyurethane composites.
【24h】

The effect of drug loading technics on in vitro release profile from multifunctional chitosan/polyurethane composites.

机译:载药工艺对多功能壳聚糖/聚氨酯复合材料体外释放特性的影响。

获取原文

摘要

Introduction: The concept of multifunctional devices that combine drug eluting components together with functional prosthetic implants, represents an emerging clinical technology that promises to provide functional enhancement to implant devices in various clinical applications'. The properly designed drug delivery system can allow for a precise drug release control, which refers to the amount of released dose, the drug release profile and the speed of release. In general, the choice of the proper drug loading technic can be decisive for obtaining the suitable and desired drug release from biomaterial. The aim of this work was to compare different methods of the drug loading into chitosan/ polyurethane matrix in terms of optimization of the developed systems. Materials and Methods: In the first stage chitosan microspheres were prepared using emulsification/cross-linking method. Chitosan solution in acidic acid containing gentamicin (3 or 6 wt. % vs. chitosan mass) was emulsified in the dispersion medium consisting of liquid paraffin stabilized by the sorbitan monooleate. Triphosphate pentasodium (TPP) and glutaraldehyde (25 or 50 wt.% solution in H2O) were used as a cross-linking agents. Next the microspheres loaded with gentamicin were added to the synthesis of polyurethane matrix (PU). PU networks based on three-branched hydroxyl terminated caprolactone (CL) and glycolide-co-lactide (PLGA) oligomers were synthesized using 1,6-hexamethylene diisocyanate (HMDI) and dibutyltin dilaurate as the catalyst. Additionally, polyurethanes consisting of chitosan macromolecule segment were synthesized and drugs were incorporated directly into the polymer matrix during synthesis. In vitro release study was performed after immersion of the composites in PBS according to the method used by Zang. Results and Discussion: Two types of biodegradable polyurethane composites containing chitosan microspheres or chitosan macromolecule segments were obtained. Chitosan microspheres with mean diameter of 8 urn (Fig.1) were distributed within polymer matrix. Drug loading efficiency in case of microspheres system increased significantly form 3% for microspheres crosslinked with 50 wt.% glutaraldehyde to 60% for microspheres crosslinked with 25 wt%. glutaraldehyde. Drug release profile from the gentamicin containing-microspheres composites proved to be stable and sustained for more than a month (Fig. 2.). In case of the polyurethane composites containing the microspheres with the drug loaded directly to the polymer matrix, the higher burst release was observed due to the facilitated diffusion of the drug. Conclusion: The results of drug release study showed that the drug release kinetics from the chitosan/polyurethane composites system can be modified by drug loading method and the cross-linking degree of chitosan microspheres. The study confirms that these systems could be successfully used un regenerative medicine as drug carriers.
机译:简介:多功能设备的概念将药物洗脱成分与功能性假体植入物结合在一起,代表了一种新兴的临床技术,有望在各种临床应用中为植入物设备提供功能上的增强。正确设计的药物输送系统可以实现精确的药物释放控制,这是指释放剂量,药物释放曲线和释放速度。通常,选择适当的药物装载技术对于从生物材料中获得合适的和所需的药物释放可能是决定性的。这项工作的目的是根据已开发系统的优化情况,比较将药物加载到壳聚糖/聚氨酯基质中的不同方法。材料和方法:在第一阶段,使用乳化/交联方法制备壳聚糖微球。将含有庆大霉素的酸性壳聚糖溶液(相对于壳聚糖质量为3或6 wt。%)在由脱水山梨糖醇单油酸酯稳定的液体石蜡组成的分散介质中进行乳化。三磷酸五钠(TPP)和戊二醛(在H2O中为25或50 wt。%的溶液)用作交联剂。接下来,将载有庆大霉素的微球添加到聚氨酯基质(PU)的合成中。以1,6-六亚甲基二异氰酸酯(HMDI)和二月桂酸二丁基锡为催化剂,合成了基于三支羟基封端己内酯(CL)和乙交酯-丙交酯(PLGA)低聚物的PU网络。另外,合成了由壳聚糖大分子链段组成的聚氨酯,并且在合成过程中将药物直接掺入了聚合物基质中。根据Zang使用的方法,将复合材料浸入PBS后进行体外释放研究。结果与讨论:获得了两种包含壳聚糖微球或壳聚糖大分子链段的可生物降解的聚氨酯复合材料。平均直径为8 mean的壳聚糖微球(图1)分布在聚合物基质中。在微球系统的情况下,载药效率显着提高,其中用50wt。%戊二醛交联的微球为3%,而用25wt%交联的微球为60%。戊二醛。含有庆大霉素的微球复合材料的药物释放曲线被证明是稳定且持续超过一个月的时间(图2)。在含有微球的聚氨酯复合材料的情况下,药物直接负载在聚合物基质上,由于药物的促进扩散,观察到较高的破裂释放。结论:药物释放研究结果表明,壳聚糖/聚氨酯复合材料体系的药物释放动力学可以通过载药方法和壳聚糖微球的交联度来改变。研究证实,这些系统可以成功地用作非再生医学的药物载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号